Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2

Abstract

Garlic-derived organosulfides (OSCs) including diallyl trisulfide (DATS) are highly effective in affording protection against chemically induced cancer in animals. Evidence is also mounting to indicate that some naturally occurring OSCs can suppress proliferation of cancer cells by causing apoptosis, but the sequence of events leading to proapoptotic effect of OSCs is poorly defined. Using PC-3 and DU145 human prostate cancer cells as a model, we now demonstrate that DATS is a significantly more potent apoptosis inducer than diallyl sulfide (DAS) or diallyl disulfide (DADS). DATS-induced apoptosis in PC-3 cells was associated with phosphorylation of Bcl-2, reduced Bcl-2 : Bax interaction, and cleavage of procaspase-9 and -3. Bcl-2 overexpressing PC-3 cells were significantly more resistant to apoptosis induction by DATS compared with vector-transfected control cells. DATS treatment resulted in activation of extracellular-signal regulated kinase 1/2 (ERK1/2) and c-jun N-terminal kinase 1 (JNK1) and/or JNK2, but not p38 mitogen-activated protein kinase. Phosphorylation of Bcl-2 in DATS-treated PC-3 cells was fully blocked in the presence of JNK-specific inhibitor SP600125. Moreover, JNK inhibitor afforded significant protection against DATS-induced apoptosis in both cells. DATS-induced Bcl-2 phosphorylation and apoptosis were partially attenuated by pharmacological inhibition of ERK1/2 using PD98059 or U0126. Overexpression of catalase inhibited DATS-mediated activation of JNK1/2, but not ERK1/2, and apoptosis induction in DU145 cells suggesting involvement of hydrogen peroxide as a second messenger in DATS-induced apoptosis. In conclusion, our data point towards important roles for Bcl-2, JNK and ERK in DATS-induced apoptosis in human prostate cancer cells.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  • Adams JM and Cory S . (1998). Science (Washington, DC), 281, 1322–1326.

  • Agarwal KC . (1996). Med. Res. Rev., 16, 111–124.

  • Blagosklonny MV . (2001). Leukemia, 15, 869–874.

  • Blagosklonny MV, Schulte T, Nguyen P, Trepel J and Neckers LM . (1996). Cancer Res., 56, 1851–1854.

  • Dausch JG and Nixon DW . (1990). Prev. Med., 19, 346–361.

  • Deng X, Xiao L, Lang W, Gao F, Ruvolo P and May WS . (2001). J. Biol. Chem., 276, 23681–23688.

  • Dorant E, van den Brandt PA, Goldbohm RA, Hermus RJ and Sturmans F . (1993). Br. J. Cancer, 67, 424–429.

  • Fang G, Chang BS, Kim CN, Perkins C, Thompson CB and Bhalla KN . (1998). Cancer Res., 58, 3202–3208.

  • Ferreira CG, Epping M, Kruyt FAE and Giaccone G . (2002). Clin. Cancer Res., 8, 2024–2034.

  • Filomeni G, Aquilano K, Rotilio G and Ciriolo MR . (2003). Cancer Res., 63, 5940–5949.

  • Haldar S, Chintapalli J and Croce CM . (1996). Cancer Res., 56, 1253–1255.

  • Haldar S, Jena N and Croce CM . (1995). Proc. Natl. Acad. Sci. USA, 92, 4507–4511.

  • Halliwell B . (1996). Biochem. Soc. Trans., 24, 1023–1027.

  • Hengartner MO . (2000). Nature (Lond.), 407, 770–776.

  • Hsing AW, Chokkalingam AP, Gao YT, Madigan MP, Deng J, Gridley G and Fraumeni Jr JF . (2002). J. Natl. Cancer Inst., 94, 1648–1651.

  • Ito T, Deng X, Carr B and May WS . (1997). J. Biol. Chem., 272, 11671–11673.

  • Knowles LM and Milner JA . (1998). Nutr. Cancer, 30, 169–174.

  • Knowles LM and Milner JA . (2001). J. Nutr., 131, 1061s–11066s.

  • Kwon KB, Yoo SJ, Ryu DG, Yang JY, Rho HW, Kim JS, Park JW, Kim HR and Park BH . (2002). Biochem. Pharmacol., 63, 41–47.

  • Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, Gillieron C, Boschert U, Vial-Knecht E, Martinou JC and Arkinstall S . (1997). J. Biol. Chem., 272, 25238–25242.

  • May WS, Tyler PG, Ito T, Armstrong DK, Qatsha KA and Davidson NE . (1994). J. Biol. Chem., 269, 26865–26870.

  • Nagae S, Ushijima M, Hatono S, Imai J, Kasuga S, Matsuura H, Itakura Y and Higashi Y . (1994). Planta Med., 60, 214–217.

  • Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki K and Tsubura A . (2001). Carcinogenesis, 22, 891–897.

  • Reddy BS, Rao CV, Rivenson A and Kelloff G . (1993). Cancer Res., 53, 3493–3498.

  • Robert V, Mouille B, Mayeur C, Michaud M and Blachier F . (2001). Carcinogenesis, 22, 1155–1161.

  • Rosini P, De Chiara G, Lucibello M, Garaci E, Cozzolino F and Torcia M . (2000). Biochem. Biophys. Res. Commun., 278, 753–759.

  • Ruvolo PP, Deng X, Carr BK and May WS . (1998). J. Biol. Chem., 273, 25436–25442.

  • Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K and Ichijo H . (1998). EMBO J., 17, 2596–2606.

  • Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD and Pietenpol JA . (1998). J. Biol. Chem., 273, 30777–30784.

  • Schaffer EM, Liu JZ, Green J, Dangler CA and Milner JA . (1996). Cancer Lett., 102, 199–204.

  • Sheen LY, Lii CK, Sheu SF, Meng RH and Tsai SJ . (1996). Food Chem. Toxicol., 34, 971–978.

  • Shirin H, Pinto JT, Kawabata Y, Soh JW, Delohery T, Moss SF, Murty V, Rivlin RS, Holt PR and Weinstein IB . (2001). Cancer Res., 61, 725–731.

  • Song JJ and Lee YJ . (2003). Biochem. J., 373, 845–853.

  • Song JJ, Rhee JG, Suntharalingam M, Walsh SA, Spitz DR and Lee YJ . (2002). J. Biol. Chem., 277, 46566–46575.

  • Sparnins VL, Barany G and Wattenberg LW . (1988). Carcinogenesis, 9, 131–134.

  • Srivastava RK, Mi Q, Hardwick JM and Longo DL . (1999). Proc. Natl. Acad. Sci. USA, 96, 3775–3780.

  • Srivastava RK, Srivastava AR, Korsmeyer SJ, Nesterova M, Cho-Chung YS and Longo DL . (1998). Mol. Cell Biol., 18, 3509–3517.

  • Sumiyoshi H and Wargovich MJ . (1990). Cancer Res., 50, 5084–5087.

  • Sundaram SG and Milner JA . (1996). Carcinogenesis, 17, 669–673.

  • Suzui N, Sugie S, Rahman KM, Ohnishi M, Yoshimi N, Wakabayashi K and Mori H . (1997). Jpn. J. Cancer Res., 88, 705–711.

  • Takahashi S, Hakoi K, Yada H, Hirose M, Ito N and Fukushima S . (1992). Carcinogenesis, 13, 1513–1518.

  • Thornberry NA and Lazebnik Y . (1998). Science (Washington, DC), 281, 1312–1316.

  • Torcia M, De Chiara G, Nencioni L, Ammendola S, Labardi D, Lucibello M, Rosini P, Marlier LNJL, Bonini P, Sbarba PD, Palamara AT, Zambrano N, Russo T, Garaci E and Cozzolino F . (2001). J. Biol. Chem., 276, 39027–39036.

  • Vantieghem A, Xu Y, Assefa Z, Piette J, Vandenheede JR, Merlevede W, de Witte PAM and Agostinis P . (2002). J. Biol. Chem., 277, 37718–37731.

  • Wang X, Martindale JL, Liu Y and Holbrook NJ . (1998). Biochem. J., 333, 291–300.

  • Wargovich MJ . (1987). Carcinogenesis, 8, 487–489.

  • Wargovich MJ, Woods C, Eng VWS, Stephens LC and Gray K . (1988). Cancer Res., 48, 6872–6875.

  • Wattenberg LW, Sparnins VL and Barany G . (1989). Cancer Res., 49, 2689–2692.

  • Xiao D, Pinto JT, Soh J, Deguchi A, Gundersen GG, Palazzo AF, Yoon J, Shirin H and Weinstein IB . (2003a). Cancer Res., 63, 6825–6837.

  • Xiao D and Singh SV . (2002). Cancer Res., 62, 3615–3619.

  • Xiao D, Srivastava SK, Lew KL, Zeng Y, Hershberger P, Johnson CS, Trump DL and Singh SV . (2003b). Carcinogenesis, 24, 891–897.

  • Yamamoto K, Ichijo H and Korsmeyer SJ . (1999). Mol. Cell. Biol., 19, 8469–8478.

  • You WC, Blot WJ, Chang YS, Ershow A, Yang ZT, An Q, Henderson BE, Fraumeni Jr JF and Wang TG . (1989). J. Natl. Cancer Inst., 81, 162–164.

Download references

Acknowledgements

This investigation was supported in part by USPHS Grants CA101753 and CA55589 (to SVS), CA95191 and CA96989 (to YJL) awarded by the National Cancer Institute. We thank Ajita V Singh, Karen L Lew and Yan Zeng for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shivendra V Singh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Xiao, D., Choi, S., Johnson, D. et al. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 23, 5594–5606 (2004). https://doi.org/10.1038/sj.onc.1207747

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207747

Keywords

This article is cited by

Search

Quick links